Cullinan Therapeutics (CGEM) Earnings Date & Reports
Cullinan Therapeutics Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CGEM is expected to report earnings to fall 20.10% to -85 cents per share on November 06
Q3'25
Est.
$-0.85
Q2'25
Missed
by $0.25
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.10
The last earnings report on August 07 showed earnings per share of -107 cents, missing the estimate of -81 cents. With 41.30K shares outstanding, the current market capitalization sits at 430.95M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEM showed earnings on August 07, 2025. You can read more about the earnings report here.